Townsend Richard Nolan 4
4 · Lexeo Therapeutics, Inc. · Filed May 20, 2025
Insider Transaction Report
Form 4
Townsend Richard Nolan
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-05-16$2.77/sh−1,074$2,979→ 221,173 total
Footnotes (2)
- [F1]Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
- [F2]Includes 133,827 RSUs.